Royalty Pharma plc
RPRX
Ранг среди акций
#867
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a... Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
Цена акции
$62.21
Последняя синхронизация: 2026-10-20
Рыночная капитализация
$27.70B
Изменение (1 день)
3.22%
Изменение (1 год)
65.98%
Страна
US
Торговля Royalty Pharma plc (RPRX)
Категория
Healthcare
Коэффициент P/S для Royalty Pharma plc (RPRX)
Коэффициент P/S на October 2026 TTM: 10.31
Согласно последним финансовым отчетам и цене акций Royalty Pharma plc, текущий коэффициент P/S (TTM) составляет 10.31. В конце 2023 он составлял 5.34.
История P/S для Royalty Pharma plc с 2015 по 2026
Коэффициент P/S в конце каждого года
| Год | P/S | Изменить |
|---|---|---|
| 2026 (TTM) | 10.31 | 104.99% |
| 2024 | 5.03 | -5.87% |
| 2023 | 5.34 | -30.98% |
| 2022 | 7.74 | 7.16% |
| 2021 | 7.22 | -21.12% |
| 2020 | 9.15 | 5.36% |
| 2019 | 8.69 | -1.07% |
| 2018 | 8.78 | -10.97% |
| 2017 | 9.86 | -31.45% |
| 2016 | 14.39 | -11.98% |
| 2015 | 16.35 | 0.00% |
Коэффициент P/S для аналогичных компаний или конкурентов
| Компания | P/S | Разница P/S | Страна |
|---|---|---|---|
| - | - |
SE
|
|
| - | - |
FR
|
|
| - | - |
IT
|
|
| 15.12 | 46.67% |
US
|
|
| 2.36 | -77.11% |
HK
|
